The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06B | Chemotherapeutics for topical use | |
| 4 | D06BB | Antivirals | |
| 5 | D06BB10 | Imiquimod |
| Active Ingredient | Description | |
|---|---|---|
| Imiquimod |
Imiquimod is an immune response modifier. Saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells. Imiquimod has no direct antiviral activity. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALDARA Cream | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ZYCLARA Cream | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
